Dechra Pharmaceuticals Plc

Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals: Major
  • ISIN: GB0009633180
GBP
38.66
0.02 (0.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
Jun'18
No of Months
12
12
12
12
12
12
Operating Income
761.00
681.00
608.00
515.00
481.00
407.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
761.00
681.00
608.00
515.00
481.00
407.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
163.00
131.00
120.00
104.00
92.00
88.00
Operating Expenses
23.00
8.00
8.00
11.00
10.00
6.00
General and Administration Expenses
206.00
178.00
151.00
134.00
126.00
110.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
667.00
580.00
521.00
456.00
431.00
367.00
Operating Profit (PBDIT) excl Other Income
94.00
101.00
87.00
58.00
50.00
40.00
Other Income
0.00
5.00
-2.00
3.00
1.00
1.00
Operating Profit (PBDIT)
183.00
195.00
174.00
145.00
137.00
102.00
Interest
23.00
8.00
8.00
11.00
10.00
6.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
89.00
88.00
90.00
83.00
86.00
61.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-35.00
78.00
75.00
41.00
28.00
29.00
Provision for Tax
-8.00
19.00
18.00
7.00
-3.00
-7.00
Profit After Tax
-27.00
58.00
55.00
33.00
30.00
36.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-0.25
0.53
0.51
0.33
0.30
0.37
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Jun 2023 is 11.69% vs 12.14% in Jun 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jun 2023 is -7.29% vs 16.67% in Jun 2022

stock-summary

Interest

YoY Growth in year ended Jun 2023 is 162.50% vs 0.00% in Jun 2022

stock-summary

Profit After Tax

YoY Growth in year ended Jun 2023 is -147.94% vs 4.86% in Jun 2022

Compare Profit and Loss Results of Dechra Pharmaceuticals Plc
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(GBP)
Change(%)
No of Months
12
12
Operating Income
761.00
31,376.00
-30,615.00
-97.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
761.00
31,376.00
-30,615.00
-97.57%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
163.00
8,327.00
-8,164.00
-98.04%
Operating Expenses
23.00
644.00
-621.00
-96.43%
General and Administration Expenses
206.00
10,741.00
-10,535.00
-98.08%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
667.00
25,714.00
-25,047.00
-97.41%
Operating Profit (PBDIT) excl Other Income
94.00
5,662.00
-5,568.00
-98.34%
Other Income
0.00
931.00
-931.00
-100.00%
Operating Profit (PBDIT)
183.00
9,144.00
-8,961.00
-98.00%
Interest
23.00
644.00
-621.00
-96.43%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
89.00
2,551.00
-2,462.00
-96.51%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-35.00
3,480.00
-3,515.00
-101.01%
Provision for Tax
-8.00
526.00
-534.00
-101.52%
Profit After Tax
-27.00
2,575.00
-2,602.00
-101.05%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.2459
0.6217
-0.87
-139.55%
Profit And Loss - Net Sales
Net Sales 761.50 Million
in Jun 2023

Figures in Million
stock-summary

YoY Growth in year ended Jun 2023 is 11.69% vs 12.14% in Jun 2022

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.10 Million
in Jun 2023

Figures in Million
stock-summary

YoY Growth in year ended Jun 2023 is -7.29% vs 16.67% in Jun 2022

Profit And Loss - Interest
Interest 23.10 Million
in Jun 2023

Figures in Million
stock-summary

YoY Growth in year ended Jun 2023 is 162.50% vs 0.00% in Jun 2022

Profit And Loss - Profit After Tax
Profit After Tax -27.90 Million
in Jun 2023

Figures in Million
stock-summary

YoY Growth in year ended Jun 2023 is -147.94% vs 4.86% in Jun 2022